DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer von Hessels, Daphne, Klein Gunnewiek, Jacqueline M T, van Oort, Inge, Karthaus, Herbert F M, van Leenders, Geert J L, van Balken, Bianca, Kiemeney, Lambertus A, Witjes, J Alfred, Schalken, Jack A

Volltext

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors von de Kok, Jacques B, Verhaegh, Gerald W, Roelofs, Rian W, Hessels, Daphne, Kiemeney, Lambertus A, Aalders, Tilly W, Swinkels, Dorine W, Schalken, Jack A

Volltext

Polycomb-Group Oncogenes EZH2 , BMI1 , and RING1 Are Overexpressed in Prostate Cancer With Adverse Pathologic and Clinical Features von van Leenders, Geert J.L.H, Dukers, Danny, Hessels, Daphne, van den Kieboom, Susan W.M, Hulsbergen, Christina A, Witjes, J. Alfred, Otte, Arie P, Meijer, Chris J, Raaphorst, Frank M

Volltext

New targets for therapy in prostate cancer: differential display code 3 ( DD3 PCA3), a highly prostate cancer–specific gene von Schalken, Jack A, Hessels, Daphne, Verhaegh, Gerald

Volltext

p53-Independent Apoptosis Induced by Menadione in the Human Colon Carcinoma Cell Line Caco-2 von KARCZEWSKI, J. M., VET, J. A. M., HESSELS, D., NOORDHOEK, J.

Volltext

Rapid microwave-stimulated fixation of entire prostatectomy specimens von Ruijter, Emiel Th, Miller, Gary J., Aalders, Tilly W., Van De Kaa, Christina A., Schalken, Jack A., Debruyne, Frans M., Boon, Mathilde E.

Volltext

Regarding: “Olloni A, et al. Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study” von Hessels, Arno C., Frederiks, Mark L., Muijs, Christina T., van Luijk, Peter

Volltext

Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer von VET, J. A. M, WITJES, J. A, MARRAS, S. A. E, HESSELS, D, VAN DER POEL, H. G, DEBRUYNE, F. M. J, SCHALKEN, J. A

Volltext

383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer von Hendriks, R.J, Dijkstra, S, Trooskens, G, Van Criekinge, W, Cornel, E.B, Jannink, S.A, De Jong, H, Hessels, D, Smit, F.P, Melchers, W.J.G, Leyten, G.H.J.M, De Reijke, T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Hulsbergen-Van De Kaa, C.A, Mulders, P.F.A, Van Oort, I.M, Van Neste, L, Schalken, J.A

Volltext

Widely used prostate carcinoma cell lines share common origins von van Bokhoven, Adrie, Varella-Garcia, Marileila, Korch, Christopher, Hessels, Daphne, Miller, Gary J.

Volltext

Applicability of biomarkers in the early diagnosis of prostate cancer von Hessels, Daphne, Verhaegh, Gerald W, Schalken, Jack A, Witjes, J Alfred

Volltext

351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer von Leyten, G.H.J.M, Hessels, D, Jannink, S.A, Smit, F.P, De Jong, H, Melchers, W.J.G, Cornel, E.B, De Reijke, T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Hulsbergen-Van De Kaa, C.A, Mulders, P.F.A, Van Oort, I.M, Schalken, J.A

Volltext

Risk factors for unplanned transfer to the intensive care unit after emergency department admission von Boerma, Lena M., MD, Reijners, Eef P.J., MD, Hessels, Roger A.P.A., MD, DEMT, v Hooft, Martijn A.A., MD

Volltext

786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS von Smit, F.P, Salagierski, M, Hessels, D, Jannink, S.A, Schalken, J.A

Volltext

913 Prospective multicenter evaluation of PCA3+TMPRSS2-ERG as a diagnostic and prognostic marker panel for prostate cancer von Leyten, G.H.J.M, Hessels, D, Cornel, E.B, De, Reijke T.M, Vergunst, H, Kil, P, Knipscheer, B.C, Van Oort, I.M, Mulders, P.F.A, Schalken, J.A

Volltext

DETECTION OF TMPRSS2-ERG FUSION TRANSCRIPTS AND PCA3 IN URINARY SEDIMENTS MAY IMPROVE DIAGNOSIS OF PROSTATE CANCER von Hessels, D, Smit, F.P, Verhaegh, G.W, Witjes, J.A, Schalken, J.A, Cornel, E.B

Volltext

896 THE EFFECT OF DUTASTERIDE ON THE PCA3 SCORE: A RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PILOT STUDY von Van, Gils M.P.M.Q, Mulders, P.F.A, Vergunst, H, Hessels, D, Peelen, W.P, Rittenhouse, H.G, Schalken, J.A

Volltext

974 PREDICTING PROSTATE BIOPSY OUTCOME IN A SCREENING SETTING PSA, PCA3, A KALLIKREIN PANEL, THE RISKCALCULATOR OR A COMBINATION? ERSPC ROTTERDAM von Roobol, M.J, Hessels, D, Vickers, A.J, Schalken, J.A, Van Leeuwen, P, Wolters, T, Van Den Berqh, R.C.N, Schröder, F.H, Lilia, H

Volltext

A 2-gene mRNA urine test for detection of high-grade prostate cancer prior to initial prostate biopsy von Schalken, J.A., Trooskens, G., Steyaert, S., Hessels, D., Brawer, M.K., Vlaeminck-Guillem, V., Groskopf, J., Van Criekinge, W., Haese, A.

Volltext

104 - A 2-gene mRNA urine test for detection of high-grade prostate cancer prior to initial prostate biopsy von Schalken, J.A., Trooskens, G., Steyaert, S., Hessels, D., Brawer, M.K., Vlaeminck-Guillem, V., Groskopf, J., Van Criekinge, W., Haese, A.

Volltext